87 related articles for article (PubMed ID: 25651789)
1. Peptide assembly integration of fibroblast-targeting and cell-penetration features for enhanced antitumor drug delivery.
Ji T; Ding Y; Zhao Y; Wang J; Qin H; Liu X; Lang J; Zhao R; Zhang Y; Shi J; Tao N; Qin Z; Nie G
Adv Mater; 2015 Mar; 27(11):1865-73. PubMed ID: 25651789
[No Abstract] [Full Text] [Related]
2. Multibarrier-penetrating drug delivery systems for deep tumor therapy based on synergistic penetration strategy.
Zhang HF; Yu H; Pan SX; Zhang C; Ma YH; Zhang YF; Zuo LL; Hao CY; Lin XY; Geng H; Wu D; Mu SQ; Yu WL; Shi NQ
Biomater Sci; 2024 Apr; 12(9):2321-2330. PubMed ID: 38488841
[TBL] [Abstract][Full Text] [Related]
3. Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation.
Ji T; Zhao Y; Ding Y; Wang J; Zhao R; Lang J; Qin H; Liu X; Shi J; Tao N; Qin Z; Nie G; Zhao Y
Angew Chem Int Ed Engl; 2016 Jan; 55(3):1050-5. PubMed ID: 26283097
[TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.
Wang W; Abbad S; Zhang Z; Wang S; Zhou J; Lv H
Curr Cancer Drug Targets; 2015; 15(4):337-51. PubMed ID: 25669720
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional biocompatible and biodegradable folic acid conjugated poly(ε-caprolactone)-polypeptide copolymer vesicles with excellent antibacterial activities.
Wang M; Zhou C; Chen J; Xiao Y; Du J
Bioconjug Chem; 2015 Apr; 26(4):725-34. PubMed ID: 25721382
[TBL] [Abstract][Full Text] [Related]
6. Optimization of the cyclotide framework to improve cell penetration properties.
Huang YH; Chaousis S; Cheneval O; Craik DJ; Henriques ST
Front Pharmacol; 2015; 6():17. PubMed ID: 25709580
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional porous silicon nanoparticles for cancer theranostics.
Wang CF; Sarparanta MP; Mäkilä EM; Hyvönen ML; Laakkonen PM; Salonen JJ; Hirvonen JT; Airaksinen AJ; Santos HA
Biomaterials; 2015 Apr; 48():108-18. PubMed ID: 25701036
[TBL] [Abstract][Full Text] [Related]
8. Enhanced serum proteolysis resistance of cell-penetrating peptides.
Fominaya J; Bravo J; Decaudin D; Brossa JY; Nemati F; Rebollo A
Ther Deliv; 2015 Feb; 6(2):139-47. PubMed ID: 25690083
[TBL] [Abstract][Full Text] [Related]
9. Cell penetrating peptides as a therapeutic strategy in chronic lymphocytic leukemia.
Arrouss I; Decaudin D; Choquet S; Azar N; Parizot C; Zini JM; Nemati F; Rebollo A
Protein Pept Lett; 2015; 22(6):539-46. PubMed ID: 25687226
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Natural Killer Cell Immunotherapy by Rationally Assembling Fc Fragments of Antibodies onto Tumor Membranes.
Ji T; Lang J; Ning B; Qi F; Wang H; Zhang Y; Zhao R; Yang X; Zhang L; Li W; Shi X; Qin Z; Zhao Y; Nie G
Adv Mater; 2019 Feb; 31(6):e1804395. PubMed ID: 30549110
[TBL] [Abstract][Full Text] [Related]
11. Reshaping Prostate Tumor Microenvironment To Suppress Metastasis
Lang J; Zhao X; Qi Y; Zhang Y; Han X; Ding Y; Guan J; Ji T; Zhao Y; Nie G
ACS Nano; 2019 Nov; 13(11):12357-12371. PubMed ID: 31545587
[TBL] [Abstract][Full Text] [Related]
12. Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy.
Ji T; Lang J; Wang J; Cai R; Zhang Y; Qi F; Zhang L; Zhao X; Wu W; Hao J; Qin Z; Zhao Y; Nie G
ACS Nano; 2017 Sep; 11(9):8668-8678. PubMed ID: 28806504
[TBL] [Abstract][Full Text] [Related]
13. Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem.
Han X; Li Y; Xu Y; Zhao X; Zhang Y; Yang X; Wang Y; Zhao R; Anderson GJ; Zhao Y; Nie G
Nat Commun; 2018 Aug; 9(1):3390. PubMed ID: 30139933
[TBL] [Abstract][Full Text] [Related]
14. Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles.
Hu K; Miao L; Goodwin TJ; Li J; Liu Q; Huang L
ACS Nano; 2017 May; 11(5):4916-4925. PubMed ID: 28414916
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin.
Miao L; Wang Y; Lin CM; Xiong Y; Chen N; Zhang L; Kim WY; Huang L
J Control Release; 2015 Nov; 217():27-41. PubMed ID: 26285063
[TBL] [Abstract][Full Text] [Related]
16. Improving the Efficacy of Common Cancer Treatments via Targeted Therapeutics towards the Tumour and Its Microenvironment.
Cecchi D; Jackson N; Beckham W; Chithrani DB
Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399237
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Supramolecular Polymers: Designs and Applications.
Wang H; Mills J; Sun B; Cui H
Prog Polym Sci; 2024 Jan; 148():. PubMed ID: 38188703
[TBL] [Abstract][Full Text] [Related]
18. Hydration-induced Void-containing Hydrogels for Encapsulation and Sustained Release of Small Hydrophilic Molecules.
Li Q; Li X; Bury E; Koh A; Lackey K; Wesselmann U; Yaksh T; Zhao C
Adv Funct Mater; 2023 Aug; 33(34):. PubMed ID: 38046826
[TBL] [Abstract][Full Text] [Related]
19. Nucleus-Targeting Manganese Dioxide Nanoparticles Coated with the Human Umbilical Cord Mesenchymal Stem Cell Membrane for Cancer Cell Therapy.
Xie L; Zhang C; Liu M; Huang J; Jin X; Zhu C; Lv M; Yang N; Chen S; Shao M; Du X; Feng G
ACS Appl Mater Interfaces; 2023 Mar; 15(8):10541-10553. PubMed ID: 36787533
[TBL] [Abstract][Full Text] [Related]
20. Peptide-assembled nanoparticles targeting tumor cells and tumor microenvironment for cancer therapy.
Zhang M; Xu H
Front Chem; 2023; 11():1115495. PubMed ID: 36762192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
